NCT01172145

Treatment of Apathy in Alzheimer's Disease With Modafinil

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Brown University · Academic / Other
• Sex: All
• Age: 65 Years – 95 Years
• Healthy volunteers: Accepted

Summary

This study examined the effects of modafinil on apathetic symptomatology, performance of activities of daily living (ADLs) and caregiver burden in individuals with Alzheimer's disease (AD).

Conditions

• Apathy
• Alzheimer's Disease

Interventions

Type	Name	Description
DRUG	Modafinil	100 mg in the morning for the first week and 200 mg in the morning for the remaining seven weeks
DRUG	Placebo	100 mg in the morning for the first week and 200 mg in the morning for the remaining seven weeks

Timeline

• Start date: 2005-07-01
• Completion: 2007-09-01
• First posted: 2010-07-29
• Last updated: 2011-03-04
• Results posted: 2011-03-04

Locations

1 site across 1 country: United States